Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C33H58N6O5 |
| Molecular Weight | 618.8508 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CCOC(=O)[C@@H](N)C(C)C)CN1C=NC2=C1NC(N)=NC2=O
InChI
InChIKey=ACBSZTQIFTYFGH-IAPPQJPRSA-N
InChI=1S/C33H58N6O5/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(40)44-23-26(20-21-43-32(42)28(34)25(2)3)22-39-24-36-29-30(39)37-33(35)38-31(29)41/h24-26,28H,4-23,34H2,1-3H3,(H3,35,37,38,41)/t26-,28+/m1/s1
| Molecular Formula | C33H58N6O5 |
| Molecular Weight | 618.8508 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Omaciclovir (previously known as H2G), a cyclic guanosine analog that is structurally similar to acyclovir and was in clinical development for the treatment of herpesvirus infections. This drug acted against varicella-zoster virus (VZV), by the formation of high concentrations of relatively stable H2G-triphosphate, which is a potent inhibitor of the viral DNA polymerases. However, further development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Activity of H2G on human herpesvirus-6B strains either sensitive or resistant to ganciclovir. | 2010-06 |
|
| Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells. | 2009-09 |
|
| The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil. | 1998-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:17 GMT 2025
by
admin
on
Mon Mar 31 18:09:17 GMT 2025
|
| Record UNII |
506LI1B3A3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
||
|
NCI_THESAURUS |
C29575
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055396
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
DTXSID00173167
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
135399823
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
506LI1B3A3
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
DB15651
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
C152820
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
LL-15
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
195156-77-5
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105845
Created by
admin on Mon Mar 31 18:09:17 GMT 2025 , Edited by admin on Mon Mar 31 18:09:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |